Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Dexter

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacy and Pharmacology|March 1, 1997
Comparison of HPLC and enzymatic recycling assays for the measurement of oxidized glutathione in rat brainJ Sian, D T Dexter, G Cohen, et al.
Neuroreport|December 1, 2001
Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's diseaseK P Datla, M Christidou, W W Widmer, et al.
Annals of Neurology|September 1, 1994
Glutathione-related enzymes in brain in Parkinson's diseaseJ Sian, D T Dexter, A J Lees, et al.
The European Journal of Neuroscience|October 4, 2005
Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's diseaseA C Vernon, S Palmer, K P Datla, et al.
Free Radical Research|February 1, 1996
Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's diseaseJ P Spencer, A Jenner, J Butler, et al.
Journal of Neuroendocrinology|April 3, 2016
Inhibition of Leptin-ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood-Brain Barrier ModelD Gonzalez-Carter, A E Goode, R Fiammengo, et al.
Cell Death & Disease|June 15, 2013
Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signallingM G Thomas, M Saldanha, R J Mistry, et al.
Journal of Neurochemistry|June 1, 1989
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's diseaseD T Dexter, F R Wells, A J Lees, et al.
Neurogenetics|December 14, 2005
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's diseaseL B Moran, D C Duke, M Deprez, et al.
Journal of Neuroimmunology|April 14, 2012
Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expressionM Sadeghian, L Marinova-Mutafchieva, L Broom, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacy and Pharmacology|March 1, 1997
Comparison of HPLC and enzymatic recycling assays for the measurement of oxidized glutathione in rat brainJ Sian, D T Dexter, G Cohen, et al.
Neuroreport|December 1, 2001
Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's diseaseK P Datla, M Christidou, W W Widmer, et al.
Annals of Neurology|September 1, 1994
Glutathione-related enzymes in brain in Parkinson's diseaseJ Sian, D T Dexter, A J Lees, et al.
The European Journal of Neuroscience|October 4, 2005
Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's diseaseA C Vernon, S Palmer, K P Datla, et al.
Free Radical Research|February 1, 1996
Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's diseaseJ P Spencer, A Jenner, J Butler, et al.
Journal of Neuroendocrinology|April 3, 2016
Inhibition of Leptin-ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood-Brain Barrier ModelD Gonzalez-Carter, A E Goode, R Fiammengo, et al.
Cell Death & Disease|June 15, 2013
Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signallingM G Thomas, M Saldanha, R J Mistry, et al.
Journal of Neurochemistry|June 1, 1989
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's diseaseD T Dexter, F R Wells, A J Lees, et al.
Neurogenetics|December 14, 2005
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's diseaseL B Moran, D C Duke, M Deprez, et al.
Journal of Neuroimmunology|April 14, 2012
Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expressionM Sadeghian, L Marinova-Mutafchieva, L Broom, et al.
Pageof 4